Mesoporous silica nanoparticles inflame tumors to overcome anti-PD-1 resistance through TLR4-NFκB axis

BACKGROUND: The clinical benefits of antiprogrammed cell death protein 1 (PD-1) therapy are compromised by resistance in immunologically cold tumors. Convergence of immunotherapy and bioengineering is potential to overcome the resistance. Mesoporous silica nanoparticles (MSNs) are considered the mos...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Mayu, Gu, Pengfei, Yang, Yang, Yu, Luodan, Jiang, Zheshun, Li, Jingquan, Le, Yingying, Chen, Yu, Ba, Qian, Wang, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Basic Tumor Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202116/
https://www.ncbi.nlm.nih.gov/pubmed/34117115
http://dx.doi.org/10.1136/jitc-2021-002508

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202116/
https://www.ncbi.nlm.nih.gov/pubmed/34117115
http://dx.doi.org/10.1136/jitc-2021-002508

Ejemplares similares